Neuropharmacological actions of two new adrenergic beta-receptor antagonists, bunolol and H 64-52. 1972

N K Khanna, and R S Gupta, and A K Mathur, and K Gupta

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010424 Pentobarbital A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236) Mebubarbital,Mebumal,Diabutal,Etaminal,Ethaminal,Nembutal,Pentobarbital Sodium,Pentobarbital, Monosodium Salt,Pentobarbitone,Sagatal,Monosodium Salt Pentobarbital
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D002040 Levobunolol The L-Isomer of bunolol. AKBeta,Apo-Levobunolol,Betagan,Levobunolol Hydrochloride,Novo-Levobunolol,PMS-Levobunolol,Ultracortenol,Vistagan,W-7000A,ratio-Levobunolol,Apo Levobunolol,ApoLevobunolol,Novo Levobunolol,NovoLevobunolol,PMS Levobunolol,PMSLevobunolol,W 7000A,W7000A,ratio Levobunolol
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D005260 Female Females

Related Publications

N K Khanna, and R S Gupta, and A K Mathur, and K Gupta
March 1972, Indian journal of experimental biology,
N K Khanna, and R S Gupta, and A K Mathur, and K Gupta
August 1965, The Journal of pharmacology and experimental therapeutics,
N K Khanna, and R S Gupta, and A K Mathur, and K Gupta
February 1973, Life sciences. Pt. 1: Physiology and pharmacology,
N K Khanna, and R S Gupta, and A K Mathur, and K Gupta
August 1965, The Journal of pharmacology and experimental therapeutics,
N K Khanna, and R S Gupta, and A K Mathur, and K Gupta
October 1970, The Journal of pharmacology and experimental therapeutics,
N K Khanna, and R S Gupta, and A K Mathur, and K Gupta
March 1976, Current therapeutic research, clinical and experimental,
N K Khanna, and R S Gupta, and A K Mathur, and K Gupta
October 1970, The Journal of pharmacology and experimental therapeutics,
N K Khanna, and R S Gupta, and A K Mathur, and K Gupta
September 1974, Acta pharmaceutica Suecica,
N K Khanna, and R S Gupta, and A K Mathur, and K Gupta
July 1984, Canadian Anaesthetists' Society journal,
N K Khanna, and R S Gupta, and A K Mathur, and K Gupta
January 1967, Acta pharmacologica et toxicologica,
Copied contents to your clipboard!